Century Therapeutics (IPSC) Stock Price Target 2026

The average analyst price target for Century Therapeutics is $7.29, 364.3% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $2 to $24. The latest change came on May 27, 2026, when Mizuho initiated coverage of Century Therapeutics with an Outperform rating and a $8 price target.